A detailed history of Raymond James & Associates transactions in Milestone Scientific Inc. stock. As of the latest transaction made, Raymond James & Associates holds 12,000 shares of MLSS stock, worth $8,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,000
Previous 12,000 -0.0%
Holding current value
$8,640
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$0.85 - $1.31 $6,800 - $10,480
-8,000 Reduced 40.0%
12,000 $11,000
Q4 2021

Feb 08, 2022

BUY
$1.86 - $2.71 $7,440 - $10,840
4,000 Added 25.0%
20,000 $41,000
Q2 2021

Aug 11, 2021

BUY
$1.93 - $3.72 $30,880 - $59,520
16,000 New
16,000 $39,000

Others Institutions Holding MLSS

About MILESTONE SCIENTIFIC INC.


  • Ticker MLSS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 68,920,896
  • Market Cap $49.6M
  • Description
  • Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that...
More about MLSS
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.